- Page 1 and 2: Ready for tomorrow Growth, Competit
- Page 3 and 4: Key figures - Solvay Group Financia
- Page 5 and 6: February Perfluoropolyether Solvay
- Page 7 and 8: Strategy of sustainable and profita
- Page 9 and 10: Solvay is an independent, ethical a
- Page 11 and 12: Resources area, beginning with the
- Page 13 and 14: Chemicals Sales: EUR 3.0 billion -
- Page 15 and 16: Record operating result for Solvay
- Page 17 and 18: EUR million 2006 2007 2007/2006 Gro
- Page 19 and 20: Capital expenditures and Research a
- Page 21 and 22: Current profit before taxes amounte
- Page 23 and 24: Joachim Adam Scientific expert Phar
- Page 25 and 26: Products Our present offering inclu
- Page 27 and 28: Gerda Greeve Microbiological analys
- Page 29 and 30: Suzanne Hattink Microbiological ana
- Page 31: Wolgang Kalbe Technical Expert Adri
- Page 35 and 36: On the path of growth Paolo Bartoli
- Page 37 and 38: Energy All our extension projects i
- Page 39 and 40: expansions were successfully brough
- Page 41 and 42: New Calcium Chloride production pla
- Page 43 and 44: The “Organic” cluster: Molecula
- Page 45 and 46: Jean-Jacques Lootens Coating operat
- Page 47 and 48: PVC In a context of high oil prices
- Page 49 and 50: SOLVERA ® and FLUORLINK ® brand n
- Page 51 and 52: Despite considerable capacity incre
- Page 53 and 54: How do the Plastics Sector’s acti
- Page 55 and 56: New Business Development Thierry De
- Page 57 and 58: organized in November 2007 - each d
- Page 59 and 60: Since 2004, Solvay has been working
- Page 61 and 62: The most important development in t
- Page 63 and 64: The new river port at the Rheinberg
- Page 65 and 66: During the June 2006 strategic revi
- Page 67 and 68: They are also the “architects”
- Page 69 and 70: Financial Statements The following
- Page 71 and 72: Goodwill EUR Million Notes 2006 200
- Page 73 and 74: Fair value differences These record
- Page 75 and 76: • IFRIC 14 IAS 19 The Limit on a
- Page 77 and 78: • the assets will generate future
- Page 79 and 80: Notes to the financial statements T
- Page 81 and 82: (2) Financial data by region Group
- Page 83 and 84:
The EUR 123 million of asset impair
- Page 85 and 86:
(12b) Deferred taxes on the balance
- Page 87 and 88:
(19) Acquisition / sale of assets a
- Page 89 and 90:
The 3-year vesting period is follow
- Page 91 and 92:
(23) Goodwill EUR Million Total Gro
- Page 93 and 94:
Finance leases EUR Million Land and
- Page 95 and 96:
The table below shows the evolution
- Page 97 and 98:
The amounts recorded in the balance
- Page 99 and 100:
Actuarial assumptions used in deter
- Page 101 and 102:
The amount of the provisions reflec
- Page 103 and 104:
Cash and cash equivalents Cash and
- Page 105 and 106:
Managing the transactional exchange
- Page 107 and 108:
Financial instruments IAS 39 define
- Page 109 and 110:
(32) Contingent liabilities EUR Mil
- Page 111 and 112:
1. Market & Growth - Strategic Risk
- Page 113 and 114:
To manage legal risk Solvay maintai
- Page 115 and 116:
• Product Development Risk is Sol
- Page 117 and 118:
2007 Consolidation Scope The Group
- Page 119 and 120:
List of fully consolidated Group co
- Page 121 and 122:
Solvay Healthcare Ltd, Southampton
- Page 123 and 124:
List of proportionately consolidate
- Page 125 and 126:
ARGENTINA Inergy Automotive Systems
- Page 127 and 128:
Income statement of Solvay S.A. (su
- Page 129 and 130:
Additional comment The preparation
- Page 131 and 132:
Report on the application of the Co
- Page 133 and 134:
Introduction This report presents t
- Page 135 and 136:
June 2005 for a three-year period b
- Page 137 and 138:
certainty the shareholders authoriz
- Page 139 and 140:
Year of birth Year of 1st appointme
- Page 141 and 142:
which could potentially affect the
- Page 143 and 144:
attendance fees for participating i
- Page 145 and 146:
They are not signed, but the Chairm
- Page 147 and 148:
enewal of their terms of office, on
- Page 149 and 150:
The Solvay share compared with the
- Page 151 and 152:
ANNEXE 2 COMPENSATION POLICY FOR GE
- Page 153 and 154:
“ … I have always sought to ser
- Page 155 and 156:
1. Mr. Aloïs Michielsen (B) 2 0 0
- Page 157 and 158:
Executive Committee and General Man
- Page 159 and 160:
ABAF: Belgian Financial Analysts As
- Page 161 and 162:
Shareholders’ Diary - Tuesday May